Skip to contentpdufa.bio

VK2735 VK2735

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

VK2735 VK2735 is a Viking Therapeutics, Inc. program in obesity (weight-loss maintenance). Its next catalyst is a Readout in Q4 2027.

VKTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Indication under review: Obesity (weight-loss maintenance). Sponsor: Viking Therapeutics, Inc. (VKTX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q4 2027VKTX

Questions

When is VK2735 VK2735's next FDA decision or readout?

The next tracked catalyst for VK2735 VK2735 is a Readout in Q4 2027.

What happened at VK2735 VK2735's most recent FDA decision?

No FDA decision for VK2735 VK2735 is in our archive yet.

What is VK2735 VK2735 used for?

In our records VK2735 VK2735 is under review or in development for Obesity (weight-loss maintenance).

Who makes VK2735 VK2735?

Viking Therapeutics, Inc. (VKTX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.